Get Result The Prostate Cancer Treatment Book PDF by Grimm, Peter, Blasko, John, Sylvester, John (Paperback)

Title	The Prostate Cancer Treatment Book
Number of Pages	219 Pages
Released	1 year 5 months 24 days ago
Grade	FLAC 44.1 kHz
Size	1,198 KiloByte
File	the-prostate-cancer_FNwfj.epub
	the-prostate-cancer_cYQQy.aac
Time	58 min 58 seconds

The Prostate Cancer Treatment Book

Category: Education & Teaching, Health, Fitness & Dieting, Calendars
Author: Shawn Achor, Morton Manus
Publisher: Joy Allen
Published: 2019-12-24
Writer: Mary Ellen Taylor, Nancy Linde
Language: Japanese, Italian, German, Afrikaans
Format: epub, Audible Audiobook

Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? - PubMed - Oligometastatic prostate cancer (OMPC), generally defined by presence of five or fewer metastatic sites on imaging, represents a transitional state between localized and widespread metastatic disease and encompasses a wide spectrum of disease biologies and clinical behaviors. A collaborative effort …

Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment - The treatment landscape for metastatic castration-sensitive prostate cancer (mCSPC) has rapidly evolved over the past 5 years. Although androgen-deprivation therapy (ADT) is still the backbone of treatment, the addition of docetaxel or abiraterone acetate has improved outcomes for patients with mCSPC and become standard of care. With multiple treatment options available for patients with mCSPC, treatment selection to optimize patient outcomes has become increasingly difficult. Here, we review the clinical trials involving ADT plus docetaxel or abiraterone and provide clinicians with guidelines for treatment. Although surgery and/or radiation are standard of care for localized, intermediate- and high-risk prostate cancer, these treatments are not routinely used as part of initial treatment plans for patients with de novo mCSPC. Recent clinical data are challenging that dogma, and we review the literature on the addition of surgery and radiation to systemic therapy for mCSPC. Finally, the standard of care for o

Prostate Cancer | ScienceDirect - An important translational book bridging the gap between science ... Prostate Cancer reviews the biological processes that can be ... the scientific developments that might result in novel treatments in the future.

Conditions and Treatments | Johns Hopkins Brady Urological Institute - Expert diagnosis and novel treatment options for urologic conditions like prostate cancer, erectile dysfunction and kidney stones in locations throughout the Baltimore/ region.

6 Best New Prostate Cancer Books To Read In 2021 - A list of 6 new prostate cancer books you should read in 2021, such as Midpoint, The First Cell and They Took My Prostate.

Prostate cancer - Symptoms and causes - Prostate cancer that's detected early — when it's still confined to the prostate gland — has the best chance for successful treatment. Products & Services. Book: ...

Prostate Cancer - Worldwide, prostate cancer is the most commonly diagnosed male malignancy and the fourth leading cause of cancer death in men.[1][2]  In 2018, this amounted to 1,280,000 newly diagnosed cases and 359,000 deaths around the world from this disease.[1][2][3][1]

Prostate Cancer - 2nd Edition - Sep 24, 2015 ... Print Book & E-Book. ... Prostate Cancer, Science and Clinical Practice, Second Edition, continues ... Are prostate cancer treatments effective?

Image Guided Prostate Cancer Treatments | Robert L. Bard | Springer - Image-Guided Prostate Cancer Treatments is a comprehensive reference and practical guide on the technology and application of ultrasound and MRI in the male pelvis, with special attention to the prostate. The book is organized into three main sections, the first of which is devoted to

Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? - Oligometastatic prostate cancer (OMPC), generally defined by presence of five or fewer metastatic sites on imaging, represents a transitional state between localized and widespread metastatic disease and encompasses a wide spectrum of disease biologies and clinical behaviors. A collaborative effort is ongoing to determine the genomics of OMPC. The prevalence of OMPC varies significantly in the literature and is likely to change further as substantial improvements in imaging improve our ability to reclassify a subset of patients with biochemical recurrence by conventional imaging as OMPC and another subset from OMPC to polymetastatic disease. The mainstay of OMPC treatment remains systemic therapy, either with androgen-deprivation therapy (ADT) alone or in combination with other agents (docetaxel, abiraterone, etc.). Focal therapies, including resection or radiotherapy (RT), to the primary tumor have demonstrated an improvement in outcomes, including failure-free survival in several retrospective studies. RT t

[pdf], [audible], [online], [download], [goodreads], [read], [audiobook], [epub], [kindle], [english], [free]